Treatment recommendations for cystic fibrosis-related diabetes: too little, too late? | Thorax

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Article info

Editorial

Treatment recommendations for cystic fibrosis-related diabetes: too little, too late?

Free

Authors

Brandon Nathan PubMed articles Google scholar articles
Antoinette Moran PubMed articles Google scholar articles

Correspondence to Brandon Nathan, Pediatric Endocrinology, University of Minnesota, 13-124 PWB, MMC 404, 516 Delaware St. SE, Minneapolis, MN 55455, USA; natha039{at}umn.edu

Citation

Nathan B, Moran A

Treatment recommendations for cystic fibrosis-related diabetes: too little, too late?

Thorax 2011;66:555-556.

Publication history

First published May 4, 2011.

Online issue publication

September 01, 2022

Article Versions

Previous version (29 April 2016).
You are viewing the most recent version of this article.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2011, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.